ALA 15.6% 18.5¢ arovella therapeutics limited

Ann: Appendix 4C - quarterly, page-22

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,020 Posts.
    lightbulb Created with Sketch. 781
    Beale/others: Do not really understand why SUD holders are so afraid of a potential CR?! After all, small companies like SUDA do need adequate funding going forward and I would rather like to see the company well-funded than under-funded.
    It is normal for an investor in the biotech/small pharma area to live with "ongoing dilution" for a while. (In fact shareholders normally do have the chance at the inflection point to purchase additional stock in order to not get diluted....only IF they wish to do so, of course!) Anyhow, this "issue" should not really matter too much at all IF the outcome at the end is a good/great one - as SUD holder are hoping for.
    All JIMHO, of course.
    wasa
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
0.025(15.6%)
Mkt cap ! $194.5M
Open High Low Value Volume
16.0¢ 19.0¢ 16.0¢ $1.303M 7.404M

Buyers (Bids)

No. Vol. Price($)
2 167000 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.5¢ 349887 3
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.